These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5620274)

  • 1. [Disease and therapy-dependent changes in the concentration of free amino acids in the plasma in multiple myelomas].
    Stacher A; Stöckl W; Weiser M
    Wien Z Inn Med; 1967; 48(4):152-60. PubMed ID: 5620274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytogenetical and clinico-hematological changes in myeloma disease].
    Dubrova SE; Dygin VP; Ushakova EA
    Tsitologiia; 1966; 8(2):241-9. PubMed ID: 5984072
    [No Abstract]   [Full Text] [Related]  

  • 3. Acid gel reaction of serum and pyroglobulins in 5 cases of multiple myelomas and a case of macroglobulinemia.
    Viranuvatti V; Thongsomboon Y
    J Med Assoc Thai; 1971 Jan; 54(1):47-61. PubMed ID: 4993517
    [No Abstract]   [Full Text] [Related]  

  • 4. Free plasma amino acids in patients with multiple myeloma.
    Loos U; Musch E; Schulte-Vennburg M; Ferber J
    J Chemother; 1989 Jul; 1(4 Suppl):1244-5. PubMed ID: 16312850
    [No Abstract]   [Full Text] [Related]  

  • 5. [The M components in various conditions caused ny myeloma nd Walderström disease].
    Invernizzi F; Cattaneo R; Fantini F; Ciconali M
    Recenti Prog Med; 1967 Dec; 43(6):536-71. PubMed ID: 4178497
    [No Abstract]   [Full Text] [Related]  

  • 6. [2 new cases of initial or secondarily non-excreting plasma cell myelomas].
    Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of changes in serum proteins by polyacrylamide gel electrophoresis in patients with multiple myeloma].
    Guseva SA; Tishchenko LM; Minchenko ZhN
    Vrach Delo; 1985 Jan; (1):95-9. PubMed ID: 3984340
    [No Abstract]   [Full Text] [Related]  

  • 8. [On a case of immunoglobulin D plasmacytoma].
    Wiedermann D; Wiedermann B; Rádl J; Skvaril F; Vaerman JP
    Schweiz Med Wochenschr; 1967 Feb; 97(7):207-10. PubMed ID: 5589271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of myelomatosis with melphalan and testosterone. Some biochemical changes in relation to therapeutics].
    Rordam P; Thiessen B
    Folia Clin Int (Barc); 1966; 16(7):339-41. PubMed ID: 5991648
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of M-components in a large municipal hospital.
    Jensen K; Hom BL; Jensen KB; Olesen H
    Dan Med Bull; 1969 Jun; 16(6):165-70. PubMed ID: 4190828
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma.
    Caggiano V; Cuttner J; Solomon A
    Blood; 1967 Sep; 30(3):265-87. PubMed ID: 6038301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paraproteinaemic coma in multiple myeloma (author's transl)].
    Lehmkuhl G; Bauerdick H; Stuhlsatz HW
    Dtsch Med Wochenschr; 1980 Aug; 105(31):1079-83. PubMed ID: 7428622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
    Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.
    Alexanian R; Haut A; Khan AU; Lane M; McKelvey EM; Migliore PJ; Stuckey WJ; Wilson HE
    JAMA; 1969 Jun; 208(9):1680-5. PubMed ID: 5818682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the amino acid pool in multiple myelomas].
    Stacher A; Stöckl W; Weiser M
    Blut; 1969 May; 19(2):73-8. PubMed ID: 5783103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of amino acids in the serum protein fractions in myelomatosis by the combination of electrophoresis with chromatography].
    CAMURATI C; GHISELLINI F; NICOSIA U
    Chir Organi Mov; 1960; 49():267-84. PubMed ID: 13690343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience on the use of l-phenylalanin nitrogen mustard (melphalan)].
    Artigas L; Dondo Lascano F; Seoane MR; Sagasta C
    Prensa Med Argent; 1970 Mar; 57(3):142-8. PubMed ID: 4989273
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum beta-lipoprotein and other specific protein concentrations in patients with immunocytoma.
    Shulman G; Lynch SR; Bezwoda WR; Gilich GC
    J Clin Pathol; 1976 May; 29(5):458-61. PubMed ID: 180062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
    Carbone PP; Kellerhouse LE; Gehan EA
    Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Symposium on progress in clinical immunochemistry. 4. Myeloma and allied disorders].
    Umegaki K; Miyama A
    Rinsho Byori; 1970 Feb; 18(2):92-6. PubMed ID: 5462064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.